A Study to Evaluate Next Day Effects of MK-4305 on Driving Performance (MK-4305-035 AM1)

NCT01311882 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Insomnia

Interventions

DRUG: MK-4305 40 mg
DRUG: MK-4305 20 mg
DRUG: Zopiclone
DRUG: Grossly Matching Placebo for Zopiclone
DRUG: Matching Placebo for MK-4305

Sponsor

Merck Sharp & Dohme LLC